Ligand validation:5LVX

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5LVX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5LVX_NAG_B_503	26%	41%	0.137	0.778	0.66	1.6	-	5	0	0	100%	0.9333
5LVX_NAG_D_507	21%	52%	0.148	0.758	0.52	1.31	-	1	0	0	100%	0.9333
3RIL_NAG_B_508	100%	9%	0.032	0.991	2.01	2.42	3	5	3	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
3GXI_NAG_C_498	100%	42%	0.035	0.985	0.9	1.34	1	2	0	0	100%	0.9333
3GXF_NAG_C_513	83%	28%	0.108	0.967	0.92	1.92	-	5	0	0	100%	0.9333
2NT1_NAG_D_498	83%	20%	0.095	0.953	0.75	2.57	-	5	2	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.